HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UVA in vivo sunscreen test method urged by Skin Cancer Foundation in comments to FDA.

This article was originally published in The Rose Sheet

Executive Summary

UVA IN VIVO SUNSCREEN TESTING METHOD URGED BY SKIN CANCER FOUNDATION in recent comments to FDA regarding the tentative final monograph for OTC sunscreens. Representing the foundation's photobiology task force, Madhu Pathak, MD, Harvard Medical School, maintains that "in the interest of general consumers and patients sensitive to UVA radiation, the FDA should not eliminate an in vivo method on human volunteers" for determining the UVA protection factor [APF] of UVA sunscreens.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005129

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel